drugset / Trial / NCT02213107
Enzalutamide & Dutasteride/Finasteride as 1st Line Treatment for Patients =/> 65 Years Old With Prostate Cancer.
NaSingle-groupOpen-labelTreatment
Summary
Determine the effect of enzalutamide and dutasteride or finasteride on the time to prostatic-specific antigen level increase in patients age 65 or older.
Timeline
- Start
- 2014-09
- Primary completion
- 2023-10-31
- Completion
- 2023-10-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dutasteride | Small molecule | — | Oral |
| Subject | Enzalutamide | Other / unclassified | — | Oral |
| Subject | Finasteride | Small molecule | — | Oral |